Calyx, Qynapse to partner on AI to analyze brain scans

By staff writers

July 25, 2022 -- Calyx and artificial intelligence (AI) neuroimaging technology firm Qynapse plan to collaborate on making Qynapse's QyScore and QyPredict algorithms available to customers developing medical treatments for central nervous system disorders.

QyScore and QyPredict help clinicians analyze and interpret brain scans, helping them determine the best treatment for conditions such as multiple sclerosis, Parkinson's, Alzheimer's, and Huntington's diseases, Calyx said.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking